WO2002004480A3 - Connective tissue growth factor-2 - Google Patents

Connective tissue growth factor-2 Download PDF

Info

Publication number
WO2002004480A3
WO2002004480A3 PCT/US2001/021799 US0121799W WO0204480A3 WO 2002004480 A3 WO2002004480 A3 WO 2002004480A3 US 0121799 W US0121799 W US 0121799W WO 0204480 A3 WO0204480 A3 WO 0204480A3
Authority
WO
WIPO (PCT)
Prior art keywords
polypeptide
present
growth factor
connective tissue
tissue growth
Prior art date
Application number
PCT/US2001/021799
Other languages
French (fr)
Other versions
WO2002004480A2 (en
Inventor
Haodong Li
Mark D Adams
Valerie Calenda
Virginie Fataccioli
Original Assignee
Human Genome Sciences Inc
Transgene Sa
Haodong Li
Mark D Adams
Valerie Calenda
Virginie Fataccioli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Human Genome Sciences Inc, Transgene Sa, Haodong Li, Mark D Adams, Valerie Calenda, Virginie Fataccioli filed Critical Human Genome Sciences Inc
Priority to CA002412124A priority Critical patent/CA2412124A1/en
Priority to AU2001276868A priority patent/AU2001276868A1/en
Priority to EP01954638A priority patent/EP1373299A4/en
Publication of WO2002004480A2 publication Critical patent/WO2002004480A2/en
Publication of WO2002004480A3 publication Critical patent/WO2002004480A3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Abstract

The present invention relates to a human CTGH-2 polypeptide and DNA (RNA) encoding such polypeptide. Also provided is a procedure for producing such polypeptide by recombinant techniques and antibodies and antagonist/inhibitors against such polypeptide. Also provided are methods of using the polypeptide therapeutically for stimulating angiogenesis enhancing the repair of connective and support tissue, promoting the attachment, fixation and stabilization of tissue implants and enhancing wound healing. Diagnostic assays for identifying mutations in nucleic acid sequence encoding a polypeptide of the present invention and for detecting altered levels of the polypeptide of the present invention are also disclosed.
PCT/US2001/021799 2000-07-11 2001-07-11 Connective tissue growth factor-2 WO2002004480A2 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
CA002412124A CA2412124A1 (en) 2000-07-11 2001-07-11 Connective tissue growth factor-2
AU2001276868A AU2001276868A1 (en) 2000-07-11 2001-07-11 Connective tissue growth factor-2
EP01954638A EP1373299A4 (en) 2000-07-11 2001-07-11 Connective tissue growth factor-2

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US21740200P 2000-07-11 2000-07-11
US60/217,402 2000-07-11
US29164201P 2001-05-18 2001-05-18
US60/291,642 2001-05-18

Publications (2)

Publication Number Publication Date
WO2002004480A2 WO2002004480A2 (en) 2002-01-17
WO2002004480A3 true WO2002004480A3 (en) 2003-10-16

Family

ID=26911905

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2001/021799 WO2002004480A2 (en) 2000-07-11 2001-07-11 Connective tissue growth factor-2

Country Status (4)

Country Link
EP (1) EP1373299A4 (en)
AU (1) AU2001276868A1 (en)
CA (1) CA2412124A1 (en)
WO (1) WO2002004480A2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002055705A2 (en) * 2001-01-11 2002-07-18 Curagen Corp Proteins and nucleic acids encoding same
TW201102086A (en) 2009-06-04 2011-01-16 Hoffmann La Roche Antibodies against human CCN1 and uses thereof
WO2011107590A1 (en) * 2010-03-04 2011-09-09 Wolfgang Poller Cnn1 (cyr61) for prevention and therapy of inflammatory disease
KR102586165B1 (en) * 2019-10-02 2023-10-10 아주대학교산학협력단 Tissue consolidant composition with increased adhesion and binding force to biological tissues and preparing method thereof

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5792453A (en) * 1995-02-28 1998-08-11 The Regents Of The University Of California Gene transfer-mediated angiogenesis therapy
US5837258A (en) * 1991-08-30 1998-11-17 University Of South Florida Induction of tissue, bone or cartilage formation using connective tissue growth factor
US5944710A (en) * 1996-06-24 1999-08-31 Genetronics, Inc. Electroporation-mediated intravascular delivery
US6069006A (en) * 1991-08-30 2000-05-30 University Of South Florida Connective tissue growth factor (CTGF) regulatory nucleic acid sequences
WO2000035939A2 (en) * 1998-12-14 2000-06-22 University Of Miami Connective tissue growth factor fragments and methods and uses thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE259419T1 (en) * 1996-03-15 2004-02-15 Munin Corp HUMAN CYR61, AN EXTRACELLULAR MATRIX SIGNALING MOLECULE

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5837258A (en) * 1991-08-30 1998-11-17 University Of South Florida Induction of tissue, bone or cartilage formation using connective tissue growth factor
US6069006A (en) * 1991-08-30 2000-05-30 University Of South Florida Connective tissue growth factor (CTGF) regulatory nucleic acid sequences
US5792453A (en) * 1995-02-28 1998-08-11 The Regents Of The University Of California Gene transfer-mediated angiogenesis therapy
US5944710A (en) * 1996-06-24 1999-08-31 Genetronics, Inc. Electroporation-mediated intravascular delivery
WO2000035939A2 (en) * 1998-12-14 2000-06-22 University Of Miami Connective tissue growth factor fragments and methods and uses thereof

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of EP1373299A4 *

Also Published As

Publication number Publication date
WO2002004480A2 (en) 2002-01-17
AU2001276868A1 (en) 2002-01-21
EP1373299A4 (en) 2005-01-19
CA2412124A1 (en) 2002-01-17
EP1373299A2 (en) 2004-01-02

Similar Documents

Publication Publication Date Title
EP0804562A4 (en) Connective tissue growth factor-2
EP2258383A3 (en) Antigenic peptides derived from telomerase
CA2224093A1 (en) Human vascular endothelial growth factor 2
EP0815202A4 (en) Human tissue inhibitor of metalloproteinase-4
WO1998049300A3 (en) Truncated vegf-related proteins
EP0751992A4 (en) Vascular endothelial growth factor 2
HUP0303173A2 (en) Modified anti-egfr antibodies with reduced immunogenicity
WO2003031462A3 (en) Nogo receptor-mediated blockade of axonal growth
NO20023387L (en) Nogo receptor mediated blockade of axonal growth
AU6160201A (en) Human polypeptides causing or leading to the killing of cells including lymphoidtumor cells
DK0759067T3 (en) Transforming growth factor alpha-H1
ATE194291T1 (en) NEUTRALIZING MONOCLONAL ANTIBODIES AGAINST RESPIRATORY SYNZYTIAL VIRUS
WO2002050277A3 (en) Protein and nucleic acids encoding same
DE60203692D1 (en) LATENCY ASSOCIATED PEPTIDES OF TGF-BETA TO LATE PHARMACEUTICALLY ACTIVE PROTEINS
RU2003130638A (en) PROTEIN ASSOCIATED WITH THE DISEASE
WO2002004480A3 (en) Connective tissue growth factor-2
EP1415154A4 (en) Control of growth and repair of gastro-intestinal tissues by gastrokines and inhibitors
WO1997035976A3 (en) Epidermal differentiation factor
EP0808899A3 (en) Human marco scavenger receptor (HMarcoSR)
MX9707617A (en) Human criptin growth factor.
EP0990000A4 (en) Connective tissue growth factor-3
DE69534452D1 (en) ANTIVIRAL PROTEIN
WO2002047720A3 (en) Treatment and prevention of ebv infection and ebv-associated disorders
EP1584628A3 (en) Viral protein
WO2001074897A3 (en) Protein amf-1 to amf-10 and nucleic acids encoding the same

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
WWE Wipo information: entry into national phase

Ref document number: 2412124

Country of ref document: CA

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWE Wipo information: entry into national phase

Ref document number: 2001954638

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 2001954638

Country of ref document: EP

NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Ref document number: 2001954638

Country of ref document: EP